First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine (Q98709409)

From Wikidata
Jump to navigation Jump to search
preprint
edit
Language Label Description Also known as
English
First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine
preprint

    Statements

    0 references
    0 references
    First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine (English)
    0 references
    0 references
    0 references
    0 references
    Gary Albert
    0 references
    Patricia Reed
    0 references
    Susan Neal
    0 references
    Joyce S. Plested
    0 references
    Mingzhu Zhu
    0 references
    Shane Cloney-Clark
    0 references
    Haixia Zhou
    0 references
    Matthew B. Frieman
    0 references
    Robert E. Haupt
    0 references
    James Logue
    0 references
    Marisa McGrath
    0 references
    Stuart Weston
    0 references
    Pedro A. Piedra
    0 references
    Iksung Cho
    0 references
    Andreana Robertson
    0 references
    Chinar Desai
    0 references
    Kathleen Callahan
    0 references
    Maggie Lewis
    0 references
    Patricia Price-Abbott
    0 references
    Neil Formica
    0 references
    Vivek Shinde
    0 references
    Louis Fries
    0 references
    Jason D. Linkliter
    0 references
    Paul Griffin
    0 references
    Bethanie Wilkinson
    0 references
    Gregory M. Glenn
    0 references
    6 August 2020
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit